Related Experiment Videos

Vitamin E absorption in small premature infants

Pediatrics
|June 1, 1979
PubMed

Insights

Oral vitamin E (dl-alpha tocopherol) therapy effectively corrects deficiency in premature infants. This treatment ensures sustained normal plasma tocopherol levels, demonstrating the efficacy of oral supplementation alone.

Area of Science:

  • Neonatology
  • Nutritional Science
  • Biochemistry

Background:

  • Premature infants (<1.5 kg birth weight) are susceptible to vitamin E deficiency.
  • Vitamin E is crucial for infant development and antioxidant protection.
  • Established methods for correcting deficiency in this population are critical.

Purpose of the Study:

  • To evaluate the efficacy of oral vitamin E administration in premature infants.
  • To determine if oral therapy alone can correct vitamin E deficiency.
  • To assess plasma tocopherol levels following supplementation.

Main Methods:

  • Orogastric administration of dl-alpha tocopherol or its acetate form.
  • A second blind trial involving 28 infants receiving 25 units of dl-alpha tocopherol or placebo for six weeks.
  • Plasma tocopherol level monitoring.

Main Results:

  • Oral administration of dl-alpha tocopherol increased plasma tocopherol levels.
  • All infants receiving vitamin E supplementation maintained normal adult plasma tocopherol ranges.
  • Oral therapy alone proved sufficient for correcting vitamin E deficiency.

Conclusions:

  • Oral vitamin E therapy is an effective method for correcting vitamin E deficiency in premature infants.
  • Sustained normal plasma tocopherol levels can be achieved with oral supplementation.
  • This approach offers a viable solution for managing vitamin E status in high-risk neonates.

Related Concept Videos